ABSTRACT
The article presents results of study of issues of psychiatric care organization in mental hospital in 2015-2017. The structure, age distribution and social status of patients are analyzed on the basis of data from Psychiatric Hospital â 13 of the Moscow Health Care Department.
Subject(s)
Hospitals, Psychiatric , Mental Disorders , Humans , Mental Disorders/therapy , Moscow , Psychotherapy/organization & administrationABSTRACT
Objective. To study the efficacy and tolerability of the new anxyolytic peptide selank in comparison with phenazepam. Material and methods. A comparative study of the anxiolytic effect and tolerability of selank and phenazepam was carried out in 60 patients with phobic-anxiety- and somatoform disorders (F40.2-9, F41.1-9, F45.0-1 by ICD-10) were examined. Results Pronounced anxiolytic and mild nootropic effects of selank were demonstrated. The anxiolytic effect lasted for a week after last receiving the peptide. Selank had a positive impact on the quality of life of the patients. Conclusion. The data obtained in the study extend therapeutic possibilities in the treatment of anxiety disorders.
Subject(s)
Anti-Anxiety Agents/therapeutic use , Anxiety Disorders/drug therapy , Benzodiazepines/therapeutic use , Oligopeptides/therapeutic use , Adolescent , Adult , Anti-Anxiety Agents/adverse effects , Benzodiazepines/adverse effects , Female , Humans , Male , Middle Aged , Oligopeptides/adverse effects , Young AdultABSTRACT
Using a questionnaire of J. Cacciola et al (1977), 80 heroin addicts aged 16-45 years (65 males, 15 female) admitted to hospital in intoxication phase or in withdrawal syndrome, were examined. A statistical analysis of the results confirmed the existence of some mental disorders, the development of which indicated high probability of breaking the abstinence by a patient and disease relapse. These are depressive syndrome appearances, anxiety disorders, dysphoria and asthenia disorders. Using Shennon criterion, an extent of informativeness (significance) for some symptoms, relating to recurrence of driving for heroin, was determined. In most cases, symptom-targeted therapy reduced the driving thus preventing a disease relapse.
